SCHEMBL22407020

SCHEMBL22407020

COC(=O)C(C)(O)c1ccc(Oc2ccc(Cl)cc2)cc1F

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 1/20 0.40
P2RX3 P56373 2/20 0.38
TLR8 Q9NR97 1/20 0.38
CCNC P24863 1/20 0.38
CDK8 P49336 1/20 0.38
AR P10275 1/20 0.37
CYP1A2 P05177 2/20 0.37
CYP3A4 P08684 2/20 0.37
PPARA Q07869 2/20 0.37
MAPT P10636 2/20 0.37
MAOA P21397 1/20 0.37
MAOB P27338 1/20 0.37
MEN1 O00255 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C19 P33261 1/20 0.37
KMT2A Q03164 1/20 0.37
ELANE P08246 2/20 0.37
ABCB11 O95342 1/20 0.36
TSHR P16473 1/20 0.36
HTR2A P28223 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22439742 0.86 PPARA (0.45) MAPK14TLR8ARCYP1A2CYP3A4
SCHEMBL22406876 0.86 AR (0.48) MAPK14P2RX3TLR8CCNCCDK8
SCHEMBL22407054 0.84 MAPK14 (0.40) MAPK14CCNCCDK8CYP1A2CYP3A4
SCHEMBL11543977 0.79 PTGDR2 (0.40) MAPK14P2RX3ARCYP1A2CYP3A4
SCHEMBL8780648 0.77 HDAC6 (0.43) CYP1A2CYP3A4MAPTMEN1CYP2C19
SCHEMBL11546454 0.75 MAPK14 (0.38) MAPK14ARCYP3A4PPARAMAOA
SCHEMBL11547740 0.74 CYP1A2 (0.43) MAPK14P2RX3CYP1A2CYP3A4PPARA
SCHEMBL11544106 0.74 MAOA (0.39) MAPK14P2RX3CCNCCDK8AR
SCHEMBL22406892 0.74 LMNA (0.41) MAPK14ARMAPTMEN1KMT2A
SCHEMBL17996051 0.73 P2RX3 (0.55) P2RX3MAPTMAOAMAOBNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3712135-B1 AZOLE DERIVATIVE, INTERMEDIATE COMPOUND, METHOD FOR PRODUCING AZOLE DERIVATIVE, AGENT FOR AGRICULTURAL AND HORTICULTURAL USE, AND MATERIAL PROTECTION AGENT FOR INDUSTRIAL USE KUREHA CORP (JP) 2023-05-03 EP disclosed
CN-111032631-B Azole derivative, intermediate compound, process for producing azole derivative, agricultural and horticultural chemical, and industrial material protective agent 株式会社吴羽 2021-05-07 CN disclosed
US-10945434-B2 Azole derivative, intermediate compound, method for producing azole derivative, agricultural or horticultural chemical agent, and protective agent for industrial material KUREHA CORPORATION (JP) 2021-03-16 US disclosed
US-20200288714-A1 AZOLE DERIVATIVE, INTERMEDIATE COMPOUND, METHOD FOR PRODUCING AZOLE DERIVATIVE, AGRICULTURAL OR HORTICULTURAL CHEMICAL AGENT, AND PROTECTIVE AGENT FOR INDUSTRIAL MATERIAL KUREHA CORPORATION (JP) 2020-09-17 US disclosed
CN-111032631-A Azole derivative, intermediate compound, process for producing azole derivative, agricultural and horticultural chemical, and industrial material protective agent 株式会社吴羽 2020-04-17 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10945434-B2 Azole derivative, intermediate compound, method for producing azole derivative, agricultural or horticultural chemical agent, and protective agent for industrial material NOS2, NOS1, CYP51A1 MAPK14 429/4885P2RX3 4605/4885TLR8 1330/4885
US-20200288714-A1 AZOLE DERIVATIVE, INTERMEDIATE COMPOUND, METHOD FOR PRODUCING AZOLE DERIVATIVE, AGRICULTURAL OR HORTICULTURAL CHEMICAL AGENT, AND PROTECTIVE AGENT FOR INDUSTRIAL MATERIAL NOS2, NOS1, CYP51A1 MAPK14 429/4885P2RX3 4605/4885TLR8 1330/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.